Acarbose-induced liver injury in an anti-hepatitis C virus positive patient [3]

Digestive and Liver Disease

Volumn 33, Issue 7, 2001, Pages 615-616

  Madonia, S ^a   Pietrosi, G ^a   Pagliaro, L ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ENALAPRIL; GLIBENCLAMIDE; HEPATITIS C ANTIBODY;

AGED; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ABSORPTION; FEMALE; HUMAN; HYPERTENSION; LETTER; LIVER INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK;

ACARBOSE; AGED; DIABETES MELLITUS; FEMALE; HEPATITIS C; HEPATITIS, TOXIC; HUMANS; HYPOGLYCEMIC AGENTS; JAUNDICE; POLYMERASE CHAIN REACTION;

EID: 0034772012     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial
2. Hepatic injury caused by acarbose
3. Acarbose-induced acute severe hepatotoxicity
4. Acarbose-induced hepatic injury
5. Acarbose-induced acute hepatitis